EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Screen‐Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long‐Term Outcomes and Mortality

Iida Ahonen, Kalle Kurppa iD, Heini Huhtala iD, Katri Kaukinen iD, Laura Kivelä iD, Juha Taavela iD

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70917 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2026. Written by Iida Ahonen and 5 co-authors. Institution: Celiac Disease Research Centre, Tampere University, Tampere, Finland. Major MEDLINE topics: Celiac Disease, Diet, Gluten-Free, Mass Screening. Cited 3 times so far (Crossref); 70 references. The full text is freely available (open access, CC BY 4.0). Funded by: Tays, Lastentautien Tutkimussäätiö, Päivikki ja Sakari Sohlbergin Säätiö.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Population‐based screening for coeliac disease could reduce underdiagnosis, but benefits and harms remain debated.

Aim

We studied health outcomes in screen‐detected coeliac disease patients at diagnosis and following a long‐term gluten‐free diet.

Methods

Data were collected from Health 2000 and 2011 studies representing the Finnish population. Coeliac disease was screened in 6339 individuals by transglutaminase and endomysial antibodies, with dual seropositivity as the diagnostic criterion, histologically validated in this cohort. Survey‐weighted analyses enabled population‐level results. The follow‐up cohort comprised those participating in both time points. Mortality was assessed between 2000 and 2017.

Results

At screening, 92 (1.5%) undiagnosed coeliac disease patients and 6216 non‐coeliac controls were identified. Patients were less often smokers (11% vs. 22%, p = 0.014), more often had a history of pre‐eclampsia (13% vs. 5%, p = 0.037) and anaemia (14% vs. 6%, p = 0.012), and lower ferritin (29 vs. 68 ng/mL, p < 0.001), with an altered lipid profile including lower total cholesterol, LDL‐C, and ApoB but higher atherogenic ratios. At 11‐year follow‐up, mental health, quality of life, and cardiometabolic markers were comparable between treated coeliac disease patients ( n = 50) and non‐coeliac controls ( n = 3226). Mortality did not differ after adjustment for age and sex (HR 0.77, 95% CI 0.45–1.33).

Conclusions

Nationally screened adults with undiagnosed coeliac disease showed iron deficiency and anaemia. Long‐term dietary treatment did not adversely affect quality of life or cardiometabolic health and may prevent complications. Furthermore, mortality was comparable to the general population. The results suggest a favourable benefit‐harm balance for population‐based screening.

Subjects

MeSH terms (MEDLINE)

Celiac DiseaseDiet, Gluten-FreeMass ScreeningHumansFemaleMaleFinlandMiddle AgedAdultAgedCohort StudiesTransglutaminasesAutoantibodies

Author keywords

coeliac diseasegluten‐freepopulationquality of lifeserologytesting

Substances

TransglutaminasesAutoantibodies

Authors and institutions

  • Celiac Disease Research Centre, Tampere University, Tampere, Finland.
  • Tampere Centre for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland.
  • Department of Pediatrics, Tampere University Hospital, Well-Being Services County of Pirkanmaa, Tampere, Finland.
  • The University Consortium of Seinäjoki, Seinäjoki, Finland.
  • Faculty of Social Sciences, University of Tampere, Tampere, Finland.
  • Department of Internal Medicine, Tampere University Hospital, Well-Being Services County of Pirkanmaa, Tampere, Finland.

ORCID profiles: Kalle Kurppa, Heini Huhtala, Katri Kaukinen, Laura Kivelä, Juha Taavela

Funding

  • Tays
  • Lastentautien Tutkimussäätiö
  • Päivikki ja Sakari Sohlbergin Säätiö
  • Emil Aaltosen Säätiö
  • Suomen Lääketieteen Säätiö
  • Academy of Finland
  • Suomen Kulttuurirahasto
  • Sigrid Juséliuksen Säätiö

Cite

APA

Ahonen, I., Kurppa, K., Huhtala, H., Kaukinen, K., Kivelä, L., & Taavela, J. (2026). Screen‐Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long‐Term Outcomes and Mortality. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70917

Vancouver

Ahonen I, Kurppa K, Huhtala H, Kaukinen K, Kivelä L, Taavela J. Screen‐Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long‐Term Outcomes and Mortality. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70917

BibTeX
@article{Ahonen2026,
  author = {Ahonen, Iida and Kurppa, Kalle and Huhtala, Heini and Kaukinen, Katri and Kivelä, Laura and Taavela, Juha},
  title = {Screen‐Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long‐Term Outcomes and Mortality},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70917}
}
Start for free →